Citation profile for Pierre Johansen

Pierre Johansen : Citation Profile

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

RESEARCH ACTIVITY:

   8 years (2014 - 2022). See details.
   Cites by year: 1
   Journals where Pierre Johansen has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 3 (18.75 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pjo381
   Updated: 2024-04-18    RAS profile: 2024-03-09
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Pierre Johansen.

Is cited by:

Holle, Rolf (2)

Zucchelli, Eugenio (1)

Gil, Joan (1)

Cites to:

Gray, Alastair (1)

Main data

Where Pierre Johansen has published?

Journals with more than one article published	# docs
PharmacoEconomics	6

Recent works citing Pierre Johansen (2024 and 2023)

Year	Title of citing document

Works by Pierre Johansen:

Year	Title	Type	Cited
2014	Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations In: PLOS ONE. [Full Text][Citation analysis]	article	4
2017	Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM) In: PharmacoEconomics. [Full Text][Citation analysis]	article	6
2020	External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions In: PharmacoEconomics. [Full Text][Citation analysis]	article	1
2020	Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements In: PharmacoEconomics. [Full Text][Citation analysis]	article	1
2020	Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Out In: PharmacoEconomics. [Full Text][Citation analysis]	article	0
2021	Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions” In: PharmacoEconomics. [Full Text][Citation analysis]	article	0
2022	The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review In: PharmacoEconomics. [Full Text][Citation analysis]	article	0
2019	Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada In: PharmacoEconomics - Open. [Full Text][Citation analysis]	article	1